RedHill Biopharma (RDHL) EBITDA Margin (2012 - 2023)
RedHill Biopharma (RDHL) reported EBITDA Margin of -2736.36% for the year ended Dec 31, 2025, down 2656.63 percentage points from -79.73% a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) EBITDA Margin (2012 - 2023) Analysis & Trends
Dating back to the year ended Dec 31, 2011, RedHill Biopharma's EBITDA Margin record includes 15 years.
- EBITDA Margin has a five-year change of -2837.97 percentage points (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 ranks as the lowest annual EBITDA Margin in data going back to the year ended Dec 31, 2011.
- According to Business Quant data, EBITDA Margin came in at -79.73% in the year ended Dec 31, 2024 (+49.79 pp), -129.53% in the year ended Dec 31, 2023 (-79.67 pp), -49.85% in the year ended Dec 31, 2022 (+23.60 pp) and -73.45% in the year ended Dec 31, 2021 (-175.06 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | RedHill Biopharma | 7.09 Mn | 7.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 3,026.00% |
| Mar 31, 2023 | -795.22% |
| Dec 31, 2022 | -587.97% |
| Sep 30, 2022 | 43.29% |
| Jun 30, 2022 | 53.29% |
| Mar 31, 2022 | 131.00% |
| Dec 31, 2021 | -639.40% |
| Sep 30, 2021 | 82.86% |
| Jun 30, 2021 | 117.90% |
| Mar 31, 2021 | 90.61% |
| Dec 31, 2020 | 94.04% |
| Sep 30, 2020 | 71.29% |
| Jun 30, 2020 | 61.81% |
| Mar 31, 2020 | 1,669.13% |
| Dec 31, 2019 | 755.79% |
| Sep 30, 2019 | 723.20% |
| Jun 30, 2019 | 806.53% |
| Mar 31, 2019 | 543.70% |
| Dec 31, 2018 | 740.69% |
| Sep 30, 2018 | 442.34% |
API Access
RedHill Biopharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();